Market Pulse
Daily · Sep 17, 2026 · data.go.kr + ECOS
KOSPI
6,715.41
-2.56 (-0.04%)
KOSDAQ
822.18
+6.20 (+0.76%)
KOSPI 200
1,058.27
-1.78 (-0.17%)
USD/KRW
1,382.20
207940KOSPI·Oct 29, 2025
Spin-off likely to unlock additional value
Mirae Asset Securities published a company analysis report on Samsung Biologics (207940) titled "Spin-off likely to unlock additional value".
Summary
Covers Samsung Biologics (207940).
Covered stock
More on 207940
Order concerns ease as growth drivers expandMirae Asset Securities · Jul 27, 2026Initiating Coverage: Unwavering Growth, Time to Build ConvictionKB Securities · May 27, 2026Fair value of W106trMirae Asset Securities · Nov 24, 2025Positioning for the next leg of growthMirae Asset Securities · Jul 25, 2025CDMO and biosimilar businesses to be separatedMirae Asset Securities · May 23, 2025Earnings surpass heightened expectationsMirae Asset Securities · Apr 24, 2025Globally leading CDMO in terms of growth and marginsMirae Asset Securities · Jan 23, 2025